Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pharmacokinetics, efficacy and tolerability of reboxetine

June 3, 1997

Lilly prepares new 5-HT1F agonists

June 3, 1997

Suntory presents new glutamate receptor antagonists

June 3, 1997

Cardioprotective effects of K-7259 in rat hearts

June 2, 1997

Lilly describes agents for Alzheimer's disease

June 2, 1997

Antimigraine agents from Janssen

June 2, 1997

MS&D prepares CCK-B/gastrin receptor antagonists

June 2, 1997

Anxiolytic/nootropic agents from Asahi

May 30, 1997

Antiemetics described by Dainippon

May 30, 1997

Otsuka reports analgesic agents

May 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...